EIM
TNDM icon

Essex Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Essex Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-175,688
Closed -$4.31M – 398
2023
Q2 		$4.31M Sell
175,688
-12,025
-6% -$387K 0.6% 45
2023
Q1 		$7.62M Buy
187,713
+8,679
+5% +$359K 1.11% 15
2022
Q4 		$8.05M Sell
179,034
-39,015
-18% -$1.77M 1.25% 11
2022
Q3 		$10.4M Buy
218,049
+81,643
+60% +$4.48M 1.67% 6
2022
Q2 		$8.07M Sell
136,406
-5,772
-4% -$474K 1.3% 11
2022
Q1 		$16.5M Buy
142,178
+55,481
+64% +$6.48M 2.06% 4
2021
Q4 		$13.1M Buy
86,697
+12,109
+16% +$1.63M 1.49% 5
2021
Q3 		$8.9M Buy
74,588
+50,256
+207% +$5.54M 1.09% 13
2021
Q2 		$2.37M Sell
24,332
-2,116
-8% -$189K 0.28% 122
2021
Q1 		$2.33M Sell
26,448
-2,803
-10% -$261K 0.28% 113
2020
Q4 		$2.8M Sell
29,251
-5,455
-16% -$562K 0.35% 91
2020
Q3 		$3.94M Buy
34,706
+1,127
+3% +$118K 0.56% 38
2020
Q2 		$3.32M Sell
33,579
-162
-0.5% -$12.9K 0.54% 48
2020
Q1 		$2.17M Sell
33,741
-1,785
-5% -$125K 0.44% 61
2019
Q4 		$2.12M Sell
35,526
-50,332
-59% -$3.1M 0.26% 125
2019
Q3 		$5.06M Buy
85,858
+48,160
+128% +$3.07M 0.73% 27
2019
Q2 		$2.43M Sell
37,698
-11,455
-23% -$739K 0.33% 90
2019
Q1 		$3.12M Sell
49,153
-29,736
-38% -$1.56M 0.46% 49
2018
Q4 		$3M Buy
78,889
+26,432
+50% +$933K 0.47% 52
2018
Q3 		$2.25M Sell
52,457
-92,708
-64% -$3.24M 0.26% 111
2018
Q2 		$3.2M Sell
145,165
-111,628
-43% -$1.37M 0.4% 73
2018
Q1 		$1.27M Buy
+256,793
New +$828K 0.17% 177
2016
Q4 		– Sell
-5,745
Closed -$440K – 372
2016
Q3 		$440K Sell
5,745
-135
-2% -$9.85K 0.07% 266
2016
Q2 		$443K Sell
5,880
-64
-1% -$5.15K 0.07% 250
2016
Q1 		$518K Sell
5,944
-858
-13% -$75.1K 0.09% 219
2015
Q4 		$803K Sell
6,802
-407
-6% -$40.4K 0.13% 177
2015
Q3 		$635K Buy
+7,209
New +$839K 0.1% 198

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Essex Investment Management's TNDM Position: Q3 2023 in Review

Essex Investment Management sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 175,688 shares — an estimated $4.31M sold.

Essex Investment Management first reported a position in TNDM in Q3 2015 and held it in 27 quarters. The position peaked at $16.5M in Q1 2022. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

  • Essex Investment Management reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
  • Essex Investment Management sold 175,688 Tandem Diabetes Care shares in Q3 2023, an estimated $4.31M.
  • Essex Investment Management first reported a position in Tandem Diabetes Care in Q3 2015 and held it in 27 quarters.
  • Essex Investment Management's Tandem Diabetes Care position peaked at $16.5M in Q1 2022.
  • 226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Essex Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.